Abvc Biopharma (ABVC) EBT Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Abvc Biopharma (ABVC) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1,045.00 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -16,571.00 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -153.00 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -571.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 553.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 4,709.00 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1,911.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2,328.00 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -801,907.00 |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -13,657.00 |
| Dec 31, 2024 | -1.63 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | -24.15 Mn |
| Dec 31, 2023 | -2.36 Mn |
| Sep 30, 2023 | -1.23 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Mar 31, 2023 | 2.26 Mn |
| Dec 31, 2022 | -1.62 Mn |
| Sep 30, 2022 | -694,276.00 |
| Jun 30, 2022 | 607,021.00 |
| Mar 31, 2022 | -2.36 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | -9,875.00 |
| Jun 30, 2021 | -573,331.00 |
| Mar 31, 2021 | 123,966.00 |
| Dec 31, 2020 | -698,532.00 |
| Sep 30, 2020 | -123,509.00 |
| Jun 30, 2020 | -64,402.00 |